Pfm Health Sciences
$1.2B 13F equity value
108 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Pfm Health Sciences covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | 233,171 | $62M | 5.4% |
| AXSM | AXSOME THERAPEUTICS INC. | 219,596 | $54M | 4.7% |
| LLY | ELI LILLY & CO | 39,258 | $47M | 4.1% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 160,768 | $39M | 3.4% |
| HUM | HUMANA INC | 94,375 | $37M | 3.3% |
| UNH | UNITEDHEALTH GROUP INC | 88,276 | $37M | 3.2% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 213,407 | $36M | 3.1% |
| INBX | INHIBRX BIOSCIENCES INC | 308,385 | $29M | 2.5% |
| UTHR | UNITED THERAPEUTICS CORP DEL | 49,991 | $27M | 2.4% |
| RVMD | REVOLUTION MEDICINES INC | 143,222 | $27M | 2.3% |
Track Pfm Health Sciences's 13F portfolio: $1.2B in reported holdings, 108 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}